BUSINESS

• AnGes MG Initiates Development of Next Generation Collategene
  July 18, 2014

• OncoTherapy Appoints Prof. Nakamura as Special Science Advisor
  July 18, 2014

• Merck Serono Japan Hopes to Boost Erbitux Share by Narrowing Down CRC Patients: President
  July 17, 2014

• Chugai, Zeltia Sign Commercialization Agreement for Plitidepsin in Europe
  July 17, 2014

• AZ Begins Nexium Clinical Study for Pediatric Use in Japan
  July 17, 2014

• Ono President Professes High Hopes for Newly Approved Anticancer Drug Opdivo
  July 16, 2014

• Antiepileptic Treatment Aptiom Approved in Canada: Sumitomo Dainippon
  July 16, 2014

• Astellas Files Irribow for Diarrhea-Predominant Irritable Bowel Syndrome in Females
  July 16, 2014

• Ex-Astellas Chair Sounds Alarm over Oncology-Focused Businesses, Says Govt Finances Will Be Insufficient
  July 15, 2014

• Kyowa Kirin’s UK Subsidiary Acquires Archimedes
  July 15, 2014

• Otsuka Files NDA for Abilify Successor Drug Brexpiprazole in US
  July 15, 2014

• “Favorable Transactions” for Nesp in Return for Support in Clinical Trial: Independent Panel
  July 14, 2014

• Astellas, IBL to Study Manufacturing Method for Agent Utilizing Human Fibrinogen
  July 14, 2014

• Takata Seiyaku Looks to Sales of 30 Billion Plus Yen by 2016
  July 11, 2014

• Astellas Gearing Up to Expand Xtandi Indication Globally: Chief Medical Officer
  July 11, 2014

• Astellas Selects Anticancer FLT3/AXL Inhibitor for Fast-Track Development
  July 11, 2014

• Nippon Chemiphar Receives Approval for Actos Generic in Hong Kong: President
  July 11, 2014

• Ono to Provide University of Tokyo with Access to Its Compound Library
  July 11, 2014

• Bayer Yakuhin Adopts Unique Certificate Program to Train Cancer Sales Reps
  July 10, 2014

• Novartis Lays Out New Global Guidelines for Investigator-Led Trials
  July 10, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 545
• 546
• 547
• 548
• 549
• 550
• 551
• 552
• 553
• …
• Next ›
• 最終 »